Tmunity nabs $100M for next-gen T-cell immunotherapies – FierceBiotech
FierceBiotech |
Tmunity nabs $100M for next-gen T-cell immunotherapies
FierceBiotech The funding comes from the likes of Ping An Ventures, the Parker Institute for Cancer Immunotherapy, Gilead, the University of Pennsylvania and Lilly Asia Ventures. The “unprecedented” expertise and level of scientific thinking in the founders and … Xconomy: Tmunity Reels in $100M for “Next Generation” Cancer … Gilead, Parker Institute grab stakes in Penn immunotherapy spinout's $100 million round Carl June's Cancer Startup Raises $100 Million From Gilead, Sean … |
